Clinical Trial Update: Clinical of Hypersensitivity Reduction Efficacy on Two Toothpastes [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating hypersensitivity reduction efficacy for two Colgate toothpaste formulations has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dentin Hypersensitivity

Drugs mentioned

• Colgate hypersensitivity toothpaste A (toothpaste)
• Colgate hypersensitivity toothpaste B (toothpaste)

Snippet

Sponsor: Colgate Palmolive | Conditions: Hypersensitivity | Phase 3 | Status: COMPLETED